Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0P5MJ
|
||||
| Former ID |
DNC014346
|
||||
| Drug Name |
ERYSTAGALLIN A
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530829] | ||
| Formula |
C26H30O5
|
||||
| Canonical SMILES |
CC(=CCC1=C(C=C2C(=C1)C3C(CO2)(C4=C(O3)C(=C(C=C4)OC)CC=C<br />(C)C)O)O)C
|
||||
| InChI |
1S/C26H30O5/c1-15(2)6-8-17-12-19-23(13-21(17)27)30-14-26(28)20-10-11-22(29-5)18(9-7-16(3)4)24(20)31-25(19)26/h6-7,10-13,25,27-28H,8-9,14H2,1-5H3/t25-,26+/m0/s1
|
||||
| InChIKey |
OOAXWUFECWLVEQ-IZZNHLLZSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Inhibitor | [530829] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||